NR2F1 and neoplasm: To address the question of what impact reduction of NR2F1 expression has on the ability of tumor cells to extravasate, we downregulated NR2F1 in tumor cells using the Tet-ON-inducible shRNAmir-NR2F1 (Supplementary Fig. 5a–c), as previously described43.